SCHEMBL22011079

SCHEMBL22011079

CC(C)(C)[C@@H]1O[C@H](CO)C(O)C1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ LGALS1 P09382 2/20 0.45
▸ LGALS3 P17931 2/20 0.45
▸ LGALS9 O00182 1/20 0.45
▸ LGALS8 O00214 1/20 0.45
▸ MAPT P10636 1/20 0.44
▸ PYGB P11216 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ OGA O60502 2/20 0.38
▸ HEXA P06865 1/20 0.38
▸ HEXB P07686 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ CA12 O43570 2/20 0.36
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA9 Q16790 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17358699 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL10147764 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL10147767 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL25140767 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL19430676 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL23591372 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL264028 1.00 L3MBTL1 (0.46) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL23266122 0.98 L3MBTL1 (0.49) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL20713594 0.98 L3MBTL1 (0.49) L3MBTL1LGALS1LGALS3LGALS9LGALS8
SCHEMBL24825613 0.98 L3MBTL1 (0.49) L3MBTL1LGALS1LGALS3LGALS9LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660911-B2 Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria TRUSTEES OF BOSTON UNIVERSITY (US) 2020-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10660911-B2 Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria ATP5ME, ATP6V1E1, ATF4 L3MBTL1 3231/4885LGALS1 3884/4885LGALS3 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback